Dr Zoe Paskins's presentation from Osteoporosis 2016: Risk of fragility fracture over 10 years across eight inflammatory conditions: A UK population study.
Find out more at: https://nos.org.uk/conference
Bo Abrahamsen's presentation from Osteoporosis 2016: Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment.
Find out more at: https://nos.org.uk/conference
Bo Abrahamsen's presentation from Osteoporosis 2016: Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment.
Find out more at: https://nos.org.uk/conference
Vertebral Fracture Identification presented by Dr Andrew Pearson, Consultant Radiologist, Borders Hospital, Melrose at the fracture liaison service champions' summit 2016. #flschampions
Dr Steve Cummings presentation from Osteoporosis 2016: Patients receiving bisphosphonates should not take holidays from treatment.
Find out more at: https://nos.org.uk/conference
Dr Andrea Burden's presentation from Osteoporosis 2016: Intermittent use of high-dose glucocorticoids and risk of fracture in Denmark: A population-based case-control study.
Find out more at: https://nos.org.uk/conference
Elizabeth Curtis's presentation from Osteoporosis 2016: Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD:
Find out more at: https://nos.org.uk/conference
Sanni Ali's presentation from Osteoporosis 2016: Antidiabetic medication use and the risk of fracture amongst type 2 diabetic patients: a nested case-control study
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Prof. Nicholas Harvey's presentation from Osteoporosis 2016: Calcium, with or without vitamin D supplementation, is not associated with ischaemic heart disease or cardiac death: the UK Biobank cohort.
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Prof. Eugene McCloskey's presentation from Osteoporosis 2016: Assessment and intervention thresholds for FRAX probabilities in the UK- Impact on the need for BMD in older women with prior fracture
Find out more at: https://nos.org.uk/conference
Sarah Chiu's presentation from Osteoporosis 2016: Impact of falls on fractures and mortality – an opportunity for intervention and enhancement of fracture prediction?
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Prof. Jon Tobias's presentation from Osteoporosis 2016: Day-to-day levels of high impact physical activity are positively related to lower limb bone strength in older women: findings from a population based study using accelerometers to classify impact magnitude.
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Vertebral Fracture Identification presented by Dr Andrew Pearson, Consultant Radiologist, Borders Hospital, Melrose at the fracture liaison service champions' summit 2016. #flschampions
Dr Steve Cummings presentation from Osteoporosis 2016: Patients receiving bisphosphonates should not take holidays from treatment.
Find out more at: https://nos.org.uk/conference
Dr Andrea Burden's presentation from Osteoporosis 2016: Intermittent use of high-dose glucocorticoids and risk of fracture in Denmark: A population-based case-control study.
Find out more at: https://nos.org.uk/conference
Elizabeth Curtis's presentation from Osteoporosis 2016: Variation in UK fracture incidence by age, sex, geography, ethnicity, socioeconomic status, and time: results from the UK CPRD:
Find out more at: https://nos.org.uk/conference
Sanni Ali's presentation from Osteoporosis 2016: Antidiabetic medication use and the risk of fracture amongst type 2 diabetic patients: a nested case-control study
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Prof. Nicholas Harvey's presentation from Osteoporosis 2016: Calcium, with or without vitamin D supplementation, is not associated with ischaemic heart disease or cardiac death: the UK Biobank cohort.
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Prof. Eugene McCloskey's presentation from Osteoporosis 2016: Assessment and intervention thresholds for FRAX probabilities in the UK- Impact on the need for BMD in older women with prior fracture
Find out more at: https://nos.org.uk/conference
Sarah Chiu's presentation from Osteoporosis 2016: Impact of falls on fractures and mortality – an opportunity for intervention and enhancement of fracture prediction?
Find out more at: https://nos.org.uk/conference
Arti Gauvri Bhimjiyani's presentation from Osteoporosis 2016: The effect of social deprivation on hip fracture incidence has not changed over 10 years in England.
Find out more at: https://nos.org.uk/conference
Prof. Jon Tobias's presentation from Osteoporosis 2016: Day-to-day levels of high impact physical activity are positively related to lower limb bone strength in older women: findings from a population based study using accelerometers to classify impact magnitude.
Find out more at: https://nos.org.uk/conference
Frank de Vries's presentation from Osteoporosis 2016: The epidemiology of mortality after fragility fracture in England and Wales.
Find out more at: https://nos.org.uk/conference
Prof. Jon Tobias's presentation from Osteoporosis 2016: What are the properties of the perfect therapy?
Find out more at: https://nos.org.uk/conference
Prof. Richard Eastell's presentation from Osteoporosis 2016: Patients receiving bisphosphonates should take holidays from treatment. The case for holidays.
Find out more at: https://nos.org.uk/conference
Kate Ward's presentation from Osteoporosis 2016: Relationships between muscle function and bone microarchitecture in the Hertfordshire cohort study.
Find out more at: https://nos.org.uk/conference
Prof. Richard Keen's presentation from Osteoporosis 2016: Teaching old dogs new tricks? Combination therapy in osteoporosis.
Find out more at: https://nos.org.uk/conference
Dr Jennifer Walsh's presentation from Osteoporosis 2016: Management of osteoporosis in the young adult.
Find out more at: https://nos.org.uk/conference
Dr Rachel Tattersall's presentation from Osteoporosis 2016: Successful transition from paediatric to adult services.
Find out more at: https://nos.org.uk/conference
Dr Antony Johansen's presentation from Osteoporosis 2016: Explaining the risk of hip fracture – using data from the National Hip Fracture Database to inform surgeons, anaesthetists and their patients.
Find out more at: https://nos.org.uk/conference
Osteoporosis 2016 | Explaining the risk of hip fracture – using data from the...
Similar to Osteoporosis 2016 | Risk of fragility fracture over 10 years across eight inflammatory conditions: A UK population study: Dr Zoe Paskins #osteo2016
Low Grade Infection after Shoulder SurgeryLennard Funk
Young male patients are at greatest risk for low-grade infections following arthroscopic and open non-arthroplasty shoulder surgery. Propionibacterium acnes was the most prevalent organism. Patients presented with classical post-operative frozen shoulder symptoms, resistant to usual treatments. 80% of patients with negative cultures improved with empirical treatment.
Presentazione a cura del Dottor Riccardo Marmo - "HOT TOPICS IN GASTROENTEROLOGIA - I TUMORI DELL'APPARATO DIGERENTE: cosa è cambiato e cosa bisogna sapere" - Roma 10/11/2018
The impact of National Bowel Cancer Screening Program in AustraliaCancer Institute NSW
The full rollout of the National Bowel Cancer Screening Program (NBCSP), offering free biennial screening using immunochemical Fecal Occult Blood Test (iFOBT) for 50-74 years is targeted for 2020. In 2013-14, the overall participation rate among Australians who were invited to participate was 36%.
Continuous Update Project: Database update and systematic literature review. Presentation given by Teresa Norat, Principal Investigator Continuous Update Project, Imperial College London.
Portal vein diameter in a tertiary care centre in North-East Indiaiosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
ILRI and ACIAR One Health related research activities in Lao PDRILRI
Presentation by P. Inthavong, B. Khamlome, B. Somoulay, K. Blaszak, A. Okello, H. Holt, K. Graham, J. Allen, P. Durr and J. Gilbert at a One Health symposium conference, Luang Prabang, Laos, 5-6 September 2013.
Volumetric-Based Analysis of In-Vivo and Ex-Vivo Quantita-tive MR Diffusion P...JohnJulie1
Imaging biomarkers are needed to assess modifications in pancreatic adenocarcinoma (PA) induced by stroma-targeted therapies. The study investigates correlations between quantitative diffusion parameters obtained in vivo and ex vivo with a tumour volumetric approach and quantitative pathologic findings including fibrosis, vascular and total nuclear densities in PA
Similar to Osteoporosis 2016 | Risk of fragility fracture over 10 years across eight inflammatory conditions: A UK population study: Dr Zoe Paskins #osteo2016 (20)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Osteoporosis 2016 | Risk of fragility fracture over 10 years across eight inflammatory conditions: A UK population study: Dr Zoe Paskins #osteo2016
1. The National Institute for Health
Research School for Primary Care
Research (NIHR SPCR) is a
partnership between the
Universities of Bristol, Cambridge,
Keele, Manchester, Newcastle,
Nottingham, Oxford, Southampton
and University College London.
School for
Primary Care
Research
RISK OF FRAGILITY FRACTURE OVER
10 YEARS ACROSS EIGHT
INFLAMMATORY CONDITIONS: A UK
POPULATION STUDY
Zoe Paskins, Rebecca Whittle, Samantha
Hider, Alyshah Abdul Sultan, Edward
Roddy, Christian Mallen
2. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Background 1
• Rheumatoid Arthritis (RA) is associated with a
1.5 fold increased risk of fracture
Van Staa et al A & R 2006
• Mechanisms explaining increased fracture risk:
– Corticosteroids
– Immobility, risk of falls
– Pro-inflammatory cytokines (such as IL1, IL6, IL11,
IL15, IL17 and TNFα) act as primary mediators of
accelerated bone loss
Mundy et al Nut Rev 2007
3. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Background 2
• Other inflammatory conditions associated with increased risk
of fracture:
– Ankylosing Spondylitis (AS)
– Systemic Lupus Erythematous (SLE)
– Inflammatory Bowel Disease (IBD)
Vosse et al ARD 2008; Bultink et al OI 2014; Van Staa et al Gastroenterology 2003
• Other common primary care inflammatory conditions for which
an association with increased risk of fracture is not clear:
– Psoriasis
– Gout
– Polymyalgia rheumatica (PMR) and Giant Cell arthritis (GCA)
Dreiher et al J Inv Derm 2009, Modalshi et al 2016 Br J Derm
Dennison et al Arch Osteo 2015, Kim et al JBMR 2016, Paik et al Arth Rheum 2016, Tzeng et al 2016
4. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Aim
• To estimate and compare the population
level absolute and relative risk of fragility
fracture among patients with eight common
inflammatory conditions
5. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Method 1
• Retrospective cohort design using Clinical Practice
Research Datalink (CPRD)
• Exposed individuals
– over the age of 40 years
– with incident diagnoses of RA, AS, SLE, IBD, gout,
GCA, PMR and psoriasis were identified from 1990–
2004 and followed up until 2015
• For each exposure group, four age-, gender- and
practice-matched controls were randomly selected
6. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Method 2
• Outcome: first major osteoporotic fracture (MOF)
(WHO definition) of wrist, vertebrae, hip, humerus
• Incidence rates of MOF per 10,000 person-years,
compared to controls using Cox regression models
• Covariates:
– Baseline - patient demographics (age and gender);
lifestyle-related (body mass index, smoking status
and alcohol consumption); COPD, diabetes, renal
disease, use of HRT and thiazides
7. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Results
8. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
RA AS IBD SLE
Exposed
(n=9,187)
Unexposed
(n=35,813)
AS Exposed
(n=3083)
AS
Unexposed
(n=11947)
Exposed
(n=6,423)
Unexposed
(n=25,139)
Exposed
(n=924)
Unexposed
(n=3608)
Follow up
time;
median
(IQR)
10.10 (6.35,
13.05)
11.01 (7.09,
13.76)
11.43 (7.70,
14.51)
11.43 (7.70,
14.48)
10.92 (6.99,
13.65)
11.15 (7.47,
13.85)
11.19 (7.25,
14.17)
11.44 (7.65,
14.31)
Male; n (%) 2869
(31.23)
11226
(31.35)
1136
(36.85)
4399
(36.82)
2930
(45.62)
11,496
(45.73)
136 (14.72) 545 (15.11)
Age;
median
(IQR)
62.17
(53.63,
71.89)
62.00
(53.49,
71.50)
55.16
(47.34,
65.24)
55.21
(47.46,
65.14)
58.16
(49.13,
68.84)
58.06
(49.28,
68.48)
54.83
(47.52,
64.88)
55.00
(47.90,
64.90)
9. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Psoriasis Gout PMR GCA
Exposed
(n=24,262)
Unexposed
(n=95,290)
Exposed
(n=36,789)
Unexposed
(n=139,685)
Exposed
(n=12,178)
Unexposed
(n=46,567)
Exposed
(n=2693)
Unexposed
(n=10528)
Follow up
time;
median
(IQR)
11.29
(7.32,
14.17)
11.36
(7.49,
14.32)
10.67
(6.62,
13.34)
10.86
(6.87,
13.51)
9.27 (5.74,
12.37)
9.64 (5.99,
12.64)
9.13 (5.87,
12.39)
9.96 (6.25,
13.04)
Male; n (%) 11,919
(49.13)
46,697
(49.01)
27,169
(73.85)
102,949
(73.70)
3736
(30.68)
14137
(30.36)
778
(28.89)
2991
(28.41)
Age;
median
(IQR)
57.80
(49.27,
67.70)
57.75
(49.32,
67.49)
63.77
(53.52,
73.45)
63.22
(53.23,
72.84)
73.27
(66.19,
78.97)
72.82
(65.79,
78.38)
72.31
(65.11,
78.32)
71.99
(64.60,
77.85)
10. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Condition
Number of
exposed with
MOF Rate of MOF per 10,000 py
Adjusted Hazard
Ratio (95%
Confidence
Interval)
RA 944 101.61 (95.33, 108.30) 1.46 (1.36, 1.57)
GCA 373 146.78 (132.61, 162.46) 1.35 (1.21, 1.52)
PMR 1696 148.12 (141.24, 155.34) 1.30 (1.23, 1.37)
IBD 464 67.35 (61.49, 73.77) 1.20 (1.09, 1.33)
Psoriasis 1588 58.34 (55.54, 61.28) 1.11 (1.05, 1.17)
AS 218 61.34 (53.72, 70.05) 1.14 (0.97, 1.34)
SLE 80 78.83 (63.36, 98.21) 1.19 (0.93, 1.51)
Gout 2047 53.19 (50.94, 55.55) 0.99 (0.94, 1.04)
11. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Condition
Number of
exposed with
MOF Rate of MOF per 10,000 py
Adjusted Hazard
Ratio (95%
Confidence Interval)
RA male
female
148
796
51.03 (43.44, 59.95)
124.56 (116.20, 133.52)
1.60 (1.33, 1.94)
1.45 (1.34, 1.57)
GCA male
female
49
324
66.27 (50.08, 87.68)
179.82 (161.27, 200.50)
1.41 (1.03, 1.93)
1.35 (1.20, 1.53)
PMR male
female
244
1452
68.69 (60.59, 77.87)
183.86 (174.64, 193.56)
1.37 (1.18, 1.59)
1.30 (1.22, 1.38)
IBD male
female
103
361
32.16 (26.51, 39.01)
97.94 (88.34, 108.58)
1.12 (0.90, 1.39)
1.25 (1.11, 1.40)
Psoriasis male
female
418
1170
31.05 (28.21, 34.17)
85.03 (80.30, 90.05)
1.20 (1.07, 1.33)
1.08 (1.01, 1.15)
AS male
female
41
177
31.57 (23.25, 42.88)
78.49 (67.74, 90.94)
1.08 (0.73, 1.58)
1.16 (0.97, 1.38)
SLE male
female
4
76
27.61 (10.36, 73.56)
87.43 (69.83, 109.47)
0.93 (0.29, 2.90)
1.20 (0.93, 1.54)
Gout male
female
955
1092
32.63 (30.62, 64.77)
118.50 (11.67, 125.74)
1.06 (0.98, 1.14)
1.01 (0.94, 1.08)
12. School for Primary Care Research
The National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a
partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham,
Oxford, Southampton and University College London.
Conclusions
• Of the eight inflammatory conditions studied, RA is
associated with the highest risk of fracture (HR 1.46)
• This study reports for the first time, an increase in
fracture risk in patients with psoriasis and no increase
in fracture risk in gout
• Patients with PMR and GCA have a 1.4 fold
increased risk of fracture
• Further planned analyses include investigation of the
effect of drugs on fracture risk
13. This study was funded by the National Institute for Health Research
School for Primary Care Research (NIHR SPCR). CDM is funded by
the National Institute for Health Research (NIHR) Collaborations for
Leadership in Applied Health Research and Care West Midlands,
the NIHR School for Primary Care Research and a NIHR Research
Professorship in General Practice (NIHR-RP-2014-04-026). The
views expressed are those of the author(s) and not necessarily
those of the NHS, the NIHR or the Department of Health.
Acknowledgements
School for
Primary Care
Research
Milica Bucknall
George Peat
Kelvin Jordan
Frances Rees
Editor's Notes
Rheumatoid arthritis is the only secondary cause of osteoporosis that is considered independent of bone density in the FRAX® algorithm.
Immobility which may be associated with chronic, particularly musculoskeletal, inflammatory conditions
AS - 3 fold risk of vertebral fracture. In SLE a recent study 1.2 fold increase risk of fracture, with steroids and disease duration inc risk, in IBD – between 1.6-,1.7 increase risk of hip and vert
Risk of mi reduced in responders to antitnf only
Kim et al – no diff in fracture rates in antitnf or dmards (confounding by indication though)
Modlashi et al – Norwegian cohort HUNT 3including over 2800 patients with ps no inc in forearm or hip fracture
Gout – dennison – increased risk of fracture; Kim no inc of Non vert fracture, paik inc hip fracture in women, Tzeng inc risk all fractures allop lowered risk
Secondary aims
To investigate the impact of treatment as an effect modifier
UK – 98% pop registered with a GP
CPRD includes 6% of pop, representative of age and gender
Practices get training on coding
High level of data validity on fracture codes
The source of data for previous pop level studies looking at fractyre risk
For lifestyle-related characteristics, the measurement nearest to their index date, in the period ever prior to index date and up to 1 year after their index date, was used. BMI was categorised according to World Health Organisation classification as normal (18.5-25Kg/m2), underweight (<18.5Kg/m2), overweight (>25-29.9Kg/m2) and obese (≥30 Kg/m2).
Directed Acylic graphs used to identify minimum confounder set for adjustment for each condition
Fracture risk may be reduced because disease control better or because looked at incident cases – and thus only investigating risk in 1st 10 yrs, when we know duration of disease is a factor in risk
Further work – break down by fracture site
Look at combinations of conditions
Van staa RA – eman disease duration 4 years. Actual fracture risk in patients with duration 2-10 yrs is 1.4
Bultink – sle –. Looked over a 25 yr window. Started at 1987 including prevalent cases.
Van staa ibd study – case control. 2000 cases IBD
Vosse as study – case control. OR only significant for spinal fractures
AS http://ard.bmj.com/content/73/10/1908.full.pdf+html
Age at onset later in women